Veterinary Advantage reached out to Covetrus about how the company is responding to the COVID-19 pandemic, both internally and in its work with veterinary clinics.
Covetrus: Working To Help Flatten The Curve Read More»
Coronavirus compels shops and service providers to change platforms, procedures and even products.
Maine businesses learn to work through pandemic Read More»
The Covetrus network of pharmacies has seen a significant increase in the number of prescriptions for medications and therapeutic diet food to be filled and shipped to pet owners on behalf of their veterinarians.
We at Covetrus continue to closely monitor the coronavirus and its impact across the globe with a focus on the health and safety of our employees, customers and supply chain partners.
COVID-19 Update for Our North American Customers Read More»
David E. Shaw has informed the company that he will not stand for re-election at the company’s annual meeting of stockholders to be held in May 2020. The company has also announced that the board has nominated Sharon Wienbar for election to the Covetrus board of directors at the annual meeting of stockholders.
Covetrus Announces David E. Shaw Will Not Seek Re-election to the Company’s Board Read More»
Covetrus shares the world’s concern about the outbreak of COVID-19. Our first priority is the health and safety of our employees, supply chain partners and customers.
Covetrus Statement on Coronavirus Read More»
Covetrus announced that Benjamin Wolin will become the company’s president and chief executive officer in conjunction with the company’s fourth quarter and full year 2019 financial results.